HB0077 schedules xylazine as a Schedule III controlled substance in Illinois, with specific exemptions.
HB0077 amends the Illinois Controlled Substances Act to classify xylazine as a Schedule III controlled substance. However, it exempts xylazine from this classification under certain conditions: when used by licensed Illinois veterinarians for nonhuman species, when used by certified euthanasia technicians, and when used by wildlife biologists under veterinarian supervision. The bill also includes provisions for the Department to exempt certain compounds from the Act if they contain active medicinal ingredients without a stimulant or depressant effect on the central nervous system.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.